CalciMedica is trading 6.67% up at $2.24 after Nasdaq closed its market-value compliance matter on September 2, 2026.
- The company satisfied Nasdaq’s alternative stockholders’ equity requirement, easing immediate delisting concerns.
- It remains subject to the $1.00 minimum-bid-price requirement.
- The regular session gained 5.00% to $2.10, while the latest filing confirms the remaining compliance risk.